An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration

Anne E. Fung, Geeta A. Lalwani, Philip J. Rosenfeld, Sander R. Dubovy, Stephan Michels, William J. Feuer, Carmen A. Puliafito, Janet L. Davis, Harry W. Flynn, Maria Esquiabro

Research output: Contribution to journalArticlepeer-review

831 Scopus citations

Fingerprint

Dive into the research topics of 'An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration'. Together they form a unique fingerprint.

Medicine & Life Sciences